Clinical outcomes of immune checkpoint inhibitors for patients with recurrent or metastatic head and neck cancer: real-world data in Korea.
Hyera KimMinsuk KwonBinnari KimHyun Ae JungJong-Mu SunSe-Hoon LeeKeunchil ParkMyung-Ju AhnPublished in: BMC cancer (2020)
Consistent with previous reports, immune checkpoint inhibitors showed promising efficacy in patients with previously treated recurrent or metastatic HNC in a real-world setting.